Skip to main content
Clinical Trials/NCT01466777
NCT01466777
Unknown
N/A

Robotic-assisted vs. Traditional Laparoscopic Surgery in Treatment of Endometrial Cancer Patients

Tampere University Hospital1 site in 1 country100 target enrollmentNovember 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Endometrium Cancer
Sponsor
Tampere University Hospital
Enrollment
100
Locations
1
Primary Endpoint
the operation time
Last Updated
6 years ago

Overview

Brief Summary

The aim of this study is to compare the robotic-assisted laparoscopic surgery to the traditional laparoscopic surgery in endometrial cancer patients.

The study is prospective and the patients are randomised into two groups of 50 patients each. Randomisation is done with Minim-programme and patients age and Body mass index are taken into account.

The primary endpoint is the operation time. The number of patients in this study is based on the non-inferiority design. Presumption is that the operation time in robotic-assisted laparoscopy will be 25% longer.

Secondary endpoints include:

  1. bleeding
  2. complications
  3. conversions
  4. number of pelvic lymph nodes
Registry
clinicaltrials.gov
Start Date
November 2010
End Date
September 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Minna Mäenpää

Principal Investigator

Tampere University Hospital

Eligibility Criteria

Inclusion Criteria

  • Endometrial cancer operations, which means hysterectomy, bilateral salphingo-oophorectomy and pelvic lymphadenectomy
  • Gr 1 and 2 differentiation type

Exclusion Criteria

  • The operation cannot be made with an laparoscopy operation
  • Age more than 85 years or young under 30 years patient

Outcomes

Primary Outcomes

the operation time

Time Frame: From the beginning of first wound incision to the closure of the wounds, an expected average of 3 hours

Secondary Outcomes

  • bleeding(Duration of hospital stay, an expected average of 5 weeks)
  • Number of participants with adverse events(Duration of hospital stay, an expected average of 5 weeks)
  • Pain(Duration of hospital stay, an expected average of 5 weeks)
  • pelvic lymph node volumes(Duration of hospital stay, an expected average of 5 weeks)

Study Sites (1)

Loading locations...

Similar Trials